US Patent 12060432 Combination therapies with anti-CD38 antibodies
Patent 12060432 was granted and assigned to Janssen Biotech on August, 2024 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 8, 2020
0
Date of Patent
August 13, 2024
0
Patent Applicant
Patent Application Number
17015017
0
Patent Citations
•••
Patent Inventor Names
Parul Doshi
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 12060432 Combination therapies with anti-CD38 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.